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Modern research of pathologic scarring has been intertemporal for three centuries 
from the beginning of the 19th century to present day. Its significance and topicality is 
determined by a combination of several factors. The aetiology of keloids remained 
unknown in spite of the genetic, experimental and clinical examinations. Despite the 
different and well-known predisposing and risk factors hypertrophic scarring did not 
lose its clinical significance due to the growing number of operations in manual 
professions and the frequency of burn injuries. The schematic incision line, while 
keeping the practicality of optimal exploration in view does not take the direction of 
the lines of force into account, and often the non-adequate and traumatizing 
operation techniques result in a great number of patients consulting doctors with 
linear hypertrophic scars. J. Alibert French surgeon named the abnormal 
proliferating scars keloid after the Greek word “chele” (meaning pincer/claw) as the 
unlimitedly growing amorphous mass of scar reminded him of pincers. This terminus 
technicus, a milestone of surgery, first appeared in his 1806 Paris publication. This 
was followed by several hundreds of thousand publications dealing with pathologic 
scars in the past two centuries. In the second half of the last century, in the modern 
phase of clinical and experimental researches new and newer scar treatment 
methods were applied in a routine-like manner.  First, from the 1960s, the pressure 
garment treatment became widespread. It was followed by administering intralesional 
steroid injections in the perioperative phase. By combining the long standing 
methods, supplemented by radiotherapy, the combined/complex therapy became 
compulsory and vital to keloid treatment as it was proven long before that the 
recidivation rate was close to a 100% in cases of exclusively operative treatment. 
Later this basis combination was complemented with newer methods. In the 1980s 
the positive impact of sheetings containing silicone-polymer on scar maturation was 
recognized. The silicone gel sheeting treatment makes a positive effect by increasing 
hydration. In the last decades of the 20th century the newest techniques for the 
treatment of pathologic scarring were adapted. There were promising results with 
different lasers. Cryotherapy was also introduced, and then new, locally administrable 
medicines were implemented. These adjunct treatments can be complemented by 
other alternative methods in the postoperative phase. For measuring the efficiency of 
the various therapeutic methods and for the comparability of results there was a need 
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for an objective and quantitative scar assessment system. The leading burn and 
plastic surgery centres of the world introduced an assessment system with 
international consensus, the so-called Vancouver-scar scale, which satisfied the 
aforementioned needs and today is an applied, standard scar-scaling method. The 
exact quantitative measuring of scars is also important, as well as determining the 
subjective complaints of the patients. With the introduction of newer, wide-spread and 
widely accepted methods carrying out randomized, prospective clinical experiments, 
evaluation and comparative analysis of scar treatment methods became possible.  
Despite experimental researches and the better results of clinical treatment the 
significance of pathologic scarring and the related fields of its investigations are not 
lessened. Clinical experiences demonstrate the assumption that the emerging of the 
symptoms consist of many factors affecting simultaneously. The multi-factorial origin 
is underpinned by experimental results as well. In the future, research based on 
cellular, extracellular and molecular level may prove the roles of many factors 
unknown today. Before defining and detailing aims it would be reasonable to 
evaluate the experimental research models and a review of molecular biology of 
wound healing.  
             
                    
       2.  THE MOLECULAR BACKGROUND OF WOUND HEALING  
During the past decade examining scar healing and its research on molecular level 
was one of the most productive areas in terms of knowledge. This continuous 
development resulted in a new perspective in clinical practice, in established or still 
researched, however promising methods. To understand and examine the process of 
pathologic scarring it is necessary and vital to discuss the newest results of wound 
healing in molecular biology. It is crucial to differentiate between the acute and 
chronic wound by precisely defining them. Today’s approach is that successful 
wound healing depends on the appropriate angiogenesis, more precisely on the 
formation of new capillaries and granulation tissue. The almost outworn classification 
of the stages of wound healing process are the strongly connected inflammatory, 
proliferative and remodellization phases. Earlier these phases corresponded to the 
regeneration and reparation phases as well. This unified, clear-cut stage division 
reflecting more knowledge was further broadened, mainly with the detailed definition 
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of the angiogenesis. These new classifications and labelling represent the growth of 
knowledge. According to this the early and late phases of angiogenesis, the vascular 
proliferation and stabilization, and finally the suppression of angiogenesis can be 
differentiated. The reformation of capillaries is regulated by the complex and strongly 
connected molecules out of which the angiogenic growth factors play determinative 
role. In the structure of the extracellular matrix the so-called matrix proteins are the 
most important, the type I and III collagen, the fibronectin and tenactin. Matrix 
cytokines were known long before but the multiple bioactive role of extracellular 
matrix in scar healing was only proven recently. The regulation processes of on cell 
and tissue level materialize through receptor transmitted signalling, reexpression of 
special proteins, cytokine production, mechanic and chemical signalling, and through 
the interaction and topography of cells. Stages of normal wound healing occur along 
the delicate balance of stimulating and supremative factors. For clinicians dealing 
with disorders of scar healing so far the conventional treatment consisted of “passive” 
interventions such as transmitting antimicrobic agents, using antiseptic dressing and 
relieving tools. A change of perspective in the everyday clinical practice can only be 
reached by getting to know the molecular processes and regulation of wound 
healing, understanding the experimental methods for intensifying wound healing and 
the active participation in the promising pharmacologic treatments. 
 
     3.  AIMS 
In a decade, between 01 November 1995 and 31 October 2004 we have treated 
more than 500 patients with different types of pathological scars with a wide 
range of sizes, with diverse appearances and various localizations. We were 
searching for the solutions of those problems occurring at the treatment of pathologic 
scars, which we were facing during unsuccessful treatments by applying therapeutic 
and prophylactic methods and histopathological, immunohistochemical and electron 
microscopic examinations.  
 
1.  Is the formation of mature dermis-originated collagen fibre and its structuring to 
orderly form justifiable by the two generally recognised methods: silicone gel sheeting 
and intralesionals steroid therapy?  
 5
2.   Using transmission electron microscopic examinations, we were trying to find 
what intracellular (molecule level) changes are induced by silicon gel patch and 
intralesional steroid treatment in the process of pathological scarring?     
3. Furthermore, we compared the macroscopic – clinical morphological – and light 
microscopic cell level changes in the differently treated cases of keloids and 
hypertrophic scarring. 
4.  We were inquiring whether the compared examination results mentioned above 
approve the place of the generally recognised and widely used scar treatment 
methods in clinical practice, or they should be reconsidered and with further 
researches their role should be determined in the first-, or second line protocol?         
5.  Finally, we were aiming to work out those preventive and follow up treatment 
protocols, which are elementary to the basic treatment yet missing today.  
6.What kind of cellular and connective tissue phenomena can be detected during the 
macroscopic morphology of scar changing? What may be the conclusion for the 
clinical practice?  
7.  Which is first-, and second line therapeutic method to choose from in the case of 
hypertrophic scarring and keloids?   
 
4. THE CLINICS OF PATHOLOGIC SCARRINGS 
4.1 The Vancouver-scar scale and score 
4.2 The quantitative methods 
4.3 The aetiology of pathologic scars 
4.3.1 The causes and risk factors of hypertrophic scar formation  
4.3.2  The possible causes of keloid formation  
4.4 Preventing pathologic scar formation 
4.5 The principles of plastic surgery and the rules of operative techniques 
4.6 Methods of prevention  
 
     5. THE SILICONE GEL SHEETING TREATMENT 
 
5.1 The chemical structure and effect of silicone gel sheeting  
5.2 The clinical use of silicone gel sheeting: continuous or interrupted 
treatment 
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5.3 Silicone gel sheeting treatment protocol  
The patients used an exclusively predetermined type of sheeting (Epiderm®, 
Biodermis Corp., and USA), daily, continuously for 12 hours. The sheeting of 
appropriate size and shape exceeded the edges of scars 2-2 cm in each direction. 
The patients were thought how to use the sheeting and informed about the treatment 
and its documentation. The follow-up examinations happen in every 2 weeks. 
Besides digital photo documentation and Vancouver scoring the changes of 
subjective complaints were also recorded.  
5.4 Clinical case study 
 
     6. THE INTRALESIONAL STEROID TREATMENT 
 
6.1 The chemical structure and effect of the corticosteroid applied  
6.2 The rules of clinical use  
6.3 The intralesional steroid treatment protocol  
In our department we use triamcinolonum acetonidum (Inj. Kenalog) 2% solution 
diluted with Lidocain to 10%. One ampoule Kenalog contains 40mg of active agent, 
after dilution it contains 4mg/ml. From the solution we inject 1-1 ml per square 
centimetres with linear technique choosing the needle between 12G and 18G. The 
size of the needle depends on the status of the scar. Usually, treatments are carried 
out every two weeks according to therapy. 
6.4 Clinical case study 
 
    7. CLINICAL EXAMINATION OF SILICONE GEL SHEETING AND 
INTRALESIONAL STEROID TREATMENTS  
 
7.1  Patient group and method  
In our department, the Department of Surgery of the University of Pécs, during 
the 4-year period between 01 April 2001 and 31 March 2004 more than 250 
patients were treated with complaints cased by pathologic scars. For our 
experiment well cooperating patients were selected from the abovementioned patient 
group, out of whom 2 groups of patients suffering from keloid- and 2 groups suffering 
from hypertrophic scar were formed. In each patient group 12-12 patients were 
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treated (altogether 48 people) according to the known protocol. Control examinations 
were carried out in every 2 weeks for four months. In the patient groups the 
distribution of sexes was the following:  male:female =1:2. The average age of the 
patients was 43 years. The youngest patient was 17, the oldest 67 years old. More 
than half of the patients belonged to the age group between 30 and 50 years. The 
important risk and/or predisposing factors including accompanying illnesses, as well 
as the distribution of scars according to localization were summed up separately. 
Diabetic patient and those suffering from autoimmune illnesses were excluded, just 
like the patients receiving systemic or local steroid/non-steroid treatment for their 
accompanying illnesses. Due to the extremely god cooperation the treatment of 
patients was a 100% completed in all groups.     
 
7.2  Clinical examinations 
First the therapeutic results of both standard methods were analysed separately 
according to scar types. The dual (cross) comparative evaluation helped to determine 
the place of the methods in different protocols. 
  
7.3  The results of silicon gel sheeting and intralesional steroid treatment of 
hypertrophic scars  
The therapeutic response to intralesional steroid treatment is quicker and more 
expressed than in case of silicone gel patch, however, therapeutic response is 
significant in both cases. Considerable remission is verified by photos its most 
distinctive clinical symptom is the easy corrugation of epithelium on the surface of the 
scar. Silicone gel patch therapy becomes ineffective between the 12th -14th weeks. 
After the 8th week there was no further administration of intralesional steroids into the 
well reacting scars (to avoid unwanted local intergrowth), nevertheless the 
therapeutic effect of the drug was measurable even later on in the significant 
decrease (p>0.05) of the activity symptoms of scars. 
 
7.4  The results of silicon gel sheeting and intralesional steroid  treatment of 
keloids  
Comparing the results of the treatments it can be said that there is a quicker 
therapeutic response to intralesional steroid treatment than in case of silicone gel 
patch. As opposed to the silicone gel treatment, results of steroid treatment of keloids 
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are significant. Macroscopic morphology of scar changing on the photo 
documentation of patients supported the results, convincingly illustrating the changes 
of the MPHV-score parameters.   
 
7.5  The comparison of silicon gel sheeting treatment of hypertrophic scars   
and keloids    
Keloids hardly reacted to silicon gel patch treatment; the therapeutic response was 
not significant. Analysing the silicon gel patch treatment of the two scar types it is 
observable that in case of hypertrophic scars the effectiveness of the method marked 
and compared to keloids the difference between therapeutic response is significant 
(keloid: p>0.05, hypertrophic scar: p<0.05).  
 
7.6  The comparison of intralesional steroid treatment of hypertrophic scars   
and keloids   
The intralesional steroid treatment had significant results in treating both types of 
scar, however, in case of hypertrophic scars the effect of the treatment is more and 
more marked after the 10th week as compared to keloids, the Vancouver-score drops 
steeply. In the hypertrophic scar patient group the subjective complaints entirely 
disappeared in the 9th-10th week of the treatment. However, regarding the outcome 
there is no significant difference between the accomplished therapeutic responses of 
the two groups (p < 0.05).   
    
7.7  The change of the patients’ subjective complaints  
The change in the patients’ subjective complaints is determined by the Likert-scale. 
 
7.8  Results  
From analysing our results it can be concluded that in the treatment of hypertrophic 
scars the silicon gel sheeting treatment is effective, therefore it is the primary method 
to choose. Further results of patient groups also supported its place in therapeutic 
protocol. While treating keloids the intralesional steroid treatment first-line weapon, 
as the silicone gel sheeting had only moderate effect. With its use there was no 
significant difference in the results, therefore it only plays an adjunct role in the 
therapeutic protocol of keloids. In case of the silicone gel sheeting treatment-resistant 
hypertrophic scars, intralesional steroid treatment is the primary choice as this type of 
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scar had quick and expressed therapeutic response in case of all patients. Based on 
our clinical results we put down recommendations for therapeutic, prophylactic 
and follow-up protocols according to scar types. We differentiate so-called first 
and second-line methods. The differentiation of therapeutic methods to be displayed 
cannot be taken as a final, “gold standard” state as with the introduction of newer 
results and possible treatments the protocols are subject to change. 
   
       8.   MORPHOLOGICAL EXAMINATION OF HYPERTROPHIC AND 
KELOID SCARRING TREATED WITH SILICONE GEL SHEETING AND 
INTRALESIONAL STEROID: PATHOHISTOLOGICAL, IMMUNO-
HISTOCHEMICAL AND TRANSMISSION ELECTRON MICROSCOPIC 
RESULTS 
 
8.1 Patient groups and methods 
To be able to evaluate and compare results more completely we examined not only 
hypertrophic scars and keloid chosen from patient groups which were treated 
occurring to intralesional steroid and silicon gel patch protocol and were operated 
and removed but also untreated hypertrophic and mature scars.   
 
8.2 The results of pathohistological examinations 
We examined haematoxylin-eosin stained segments with different magnification 
(between 100x and 500x). The state of cell like elements and the connective tissue 
are even more visible with trichrome staining.  
 
8.3 The results of immunohistochemical examinations 
We examined the actin activity which was displayed the metabolic activity of 
different cellular elements. The endothel cells of atrophic scar showed metabolic 
activity moderately, while the numerous fibroblasts of hypertrophic scars and keloids  






8.4 Transmission electron microscopic examinations  
Examinations were carried out at the University of Pécs in the Central Electron 
Microscopic Laboratory with a JEOL 1200EX-II type transmission electron 
microscope. Examinations were carried out according to a precisely 
determined protocol. Electron microscopic examinations were carried out with 
magnification ranging between 5000x and 50000x. 
 
8.5 Results 
We compared results of mature scars, untreated scars and hypertrophic scars 
treated by standard therapeutic methods used as control group with the results of 
keloids. In the electron microscopic morphology of mature and different pathologic 
scars individual cellular and extracellular properties can be found. These 
characteristics did not change or disappeared as a result of standard therapeutic 
methods, only decreased to different extent. Fibroblasts examined in hypertrophic 
scars have the same characteristics as intact, dermis-originated fibroblasts; the 
difference was only observable in morphologic characteristics indicating metabolic 
activity. On the contrary, the electron microscopic structure of fibroblasts examined in 
keloids fundamentally differs from cells in the dermis of intact skin. Only in the 
cytoplasm of these fibroblasts of keloid-origin is this electrodense material observable 
– that is greatly overproduced and stored, and fills almost the entire periblast – and   
which, with pathohistological and immunohistopathological examinations proved to 
be glycoproteins (earlier labelled as mucopolysacharids). Besides, the intra- and 
extracellular position of irregularly structured pro-collagens and collagen fibrillums 
was observable. The structure of the extracellular matrix is complex; it is built up 
regularly of molecular and cellular mechanisms. In these processes glycoprotein 
molecules have an essential role because they comprise the upholder system of the 
matrix thus they are responsible for the flexibility and the stability of the scars.  The 
reason for keloid formation is unknown but keloids bear the most important and the 
highest relevancy of clinical characteristics (progressive, unrespectful growing over 
histic boundaries) which is caused by the individual structure of the extracellular 
matrix: it is specific of uncontrolled, unregulated matrix elements generating in a very 
high number. According to our present knowledge for this pathological process 
fibroblasts identified only in keloids are responsible. We named keloid originated 
fibroblasts as “keloidocytes” because they have pathognomonic value. 
 11
Researching the formation of keloidocytes may lead us closer to the final recognition 
of the aetiology of keloids. Examining DNA replication may give further knowledge as 
keloids behave as semi-malignant tumours, therefore these examinations may help 
the understanding of the biological behaviour of keloids. 
 
 
9. Novel findings 
1. It was proven by our examinations that silicon gel patch should be chosen as the 
first line treatment in cases of hypertrophic scars, while treating keloids it has only 
adjuvant role, thus in these cases the first line treatment should be the 
intralesional therapeutic method. 
2. The morphological examinations we carried out supported our clinical results that 
the silicon gel patch treatment is only effective in cases of hypertrophic scars.  
3. During the examinations of keloids by transmission electron microscope we 
detected fibroblasts at first, which can only be found and are characteristic to 
these kinds of scars. Because they have pathognomonic value, we named these 
increased quantity of keloid originated pathological fibroblasts containing glucose-
amino-glycans as keloidocytes.  
4. We revealed the fact that after administering intralesional steroids it is crucial to 
the fast therapeutic response that the medicine is immissioned into the “core” of 
the scar in order to greatly reduce activity of cell like elements in keloids.  
5. According to our clinical and histological examinations we determined therapeutic, 
prophylactic and follow up protocols of the different scar types, which may also 
serve as recommendations for plastic surgery centres. 
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